by Anton Shilov
01/07/2010 | 02:45 PM
ATI, graphics business unit of Advanced Micro Devices, said on Thursday that it had shipped its second millionth DirectX 11 graphics processing unit (GPU). It appears that it has taken AMD just about three months to ship two million of new-generation graphics chips.
"Fifteen weeks ago we introduced the ATI Radeon HD 5800 series graphics cards to the world, the first to support DirectX 11 and powerful capabilities like ATI Eyefinity multi-display technology, with support for Direct Compute 11. Over the course of the last few months, we've shipped tens of thousands of DirectX 11-capable graphics processors a week to technology partners who in turn put them into consumers' hands. With this week's introduction of the DirectX 11-capable notebook counterparts to our desktop family in the ATI Mobility Radeon HD 5000 series, an even larger base of users will enjoy the best visual computing experience available today,” said Rick Bergman, senior vice president and general manager of products group at AMD.
ATI’s DirectX 11 lineup consists of several offerings and covers performance mainstream, high-end and enthusiast market segments. The most affordable DirectX 11 graphics card – ATI Radeon HD 5750 is available for about $140 in the U.S. – whereas the most expensive – ATI Radeon HD 5970 – costs over $600. At Consumer Electronics Show ATI introduced its new ATI Mobility Radeon HD 5000 family.
Shipments of ATI’s new product family were slowed down by poor yields of 40nm chips at Taiwan Semiconductor Manufacturing Company. As a result, the actual demand towards the new high-end graphics cards from ATI/AMD is considerably higher than supply.
"Being first to market with new technology and initiatives gives a company a strong lead, and if properly managed, a sustainable advantage. AMD has been first to market with DirectX 11 graphics products, and as a result, all of the new DirectX 11 games have used those products as the basis for their development. This gives AMD a substantial advantage,” said Dr. Jon Peddie, founder and president of Jon Peddie Research.